Attenzione! I contenuti di questa pagina sono disponibili solo nelle seguenti lingue: Inglese
Comecer’s R&D activities are focused on delivering solutions that improve safety, reliability, and efficiency in pharmaceutical and radiopharmaceutical production. Continuous investment, cross-divisional collaboration, and direct customer feedback enable the development of technologies tailored to real GMP manufacturing environments.
Design capability is built on specialization and hands-on experience. Teams work closely with end users to understand process constraints, regulatory requirements, and performance expectations. This ensures that systems are not only innovative, but also practical to implement, validate, and operate.
R&D is aligned with Comecer’s industrial strategy: upgrading facilities, introducing advanced tools, and standardizing processes to increase flexibility and control costs. The goal is to develop solutions that can move efficiently from design to full-scale production.
All developments are driven by core priorities: operator protection, product integrity, and compliance with GMP standards. Systems are also engineered for usability, maintainability, and environmental responsibility.
Comecer’s R&D department is organized into specialized teams, each contributing to the development of advanced pharmaceutical and radiopharmaceutical technologies:
The integration of these disciplines allows Comecer to control the full development lifecycle, from initial design to validation and deployment. This ensures consistency across systems, reduces implementation risks, and supports reliable performance in GMP-regulated production.
Technical
Statistici
Profilazione
